Trial begins of fourth-generation ICD (implantable cardioverter defibrillator):
This article was originally published in Clinica
Executive Summary
French company ELA Medical has begun a US trial of its fourth-generation ICD, the dual chamber DEFENDER IV DR. The device, which was launched in Europe in October, uses an algorithm shown in a recent clinical study to detect more than 90% of atrial arrhythmias. A further improvement on the algorithm increases specificity for atrial fibrillation.